Operating Lease, Right-of-Use Asset of SELLAS Life Sciences Group, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
SELLAS Life Sciences Group, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • SELLAS Life Sciences Group, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $556,000, a 8.4% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

SELLAS Life Sciences Group, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $556,000 +$43,000 +8.4% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $683,000 +$50,000 +7.9% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $806,000 +$59,000 +7.9% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $925,000 +$67,000 +7.8% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $513,000 -$79,000 -13% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $633,000 -$57,000 -8.3% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $747,000 -$37,000 -4.7% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $858,000 -$16,000 -1.8% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $592,000 -$369,000 -38% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $690,000 -$355,000 -34% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $784,000 -$343,000 -30% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $874,000 +$151,000 +21% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $961,000 +$194,000 +25% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,045,000 +$233,000 +29% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $1,127,000 +$273,000 +32% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $723,000 -$173,000 -19% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $767,000 -$144,000 -16% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $812,000 -$172,000 -17% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $854,000 +$731,000 +594% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $896,000 +$679,000 +313% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $911,000 +$605,000 +198% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $984,000 +$594,000 +152% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $123,000 -$348,000 -74% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $217,000 +$217,000 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 $306,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $390,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $471,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 14 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.